google plus one (home page)

Article

Newsletter

Enhance your clinical practice with the Patient Care newsletter, offering the latest evidence-based guidelines, diagnostic insights, and treatment strategies for primary care physicians.

Subscribe Now!
Recent Videos
Related Content
nt Improvements in Hidradenitis Suppurativa Observed During Treatment with GLP-1 Receptor Agonists / image credit ©syahrir/stock.adobe.com

Improvements in Hidradenitis Suppurativa Observed During Treatment with GLP-1 Receptor Agonists

Grace Halsey
August 19th 2025
Article
The Weekly Dose: New Endocrine Guidelines, Digital Asthma Gains, AI Trust Gap, GLP-1 & Dementia Risk, First CHE Treatment

The Weekly Dose: New Endocrine Guidelines, Digital Asthma Gains, AI Trust Gap, GLP-1 & Dementia Risk, First CHE Treatment

Sydney Jennings
August 19th 2025
Podcast
Viking's Oral Dual Incretin Agonist VK2735 Produces Up to 12% Weight Loss at 13 Weeks in Phase 2 Trial

Viking's Oral Dual Incretin Agonist VK2735 Produces Up to 12% Weight Loss at 13 Weeks in Midstage Trial

Grace Halsey
August 19th 2025
Article
The Weekly Dose: Pediatric Vaccine Safety, Atopic Dermatitis, Dementia Risk, and Maternal Depression

The Weekly Dose: Pediatric Vaccine Safety, Atopic Dermatitis, Dementia Risk, and Maternal Depression

Sydney Jennings
August 19th 2025
Podcast
Investigational Psychedelic RE104 for Postpartum Depression Delivers Positive Phase 2 Results: Reunion Neuroscience Update / image credit UVA Health Anita Clayton, MD

Investigational Psychedelic RE104 for Postpartum Depression Delivers Positive Phase 2 Results: Reunion Neuroscience Update

Grace Halsey
August 19th 2025
Article
FluMist Intranasal Flu Vaccine Now Available for At-Home Delivery and Self-Administration

FluMist Intranasal Flu Vaccine Now Available for At-Home Delivery and Self-Administration

Sydney Jennings
August 19th 2025
Article
© 2025 MJH Life Sciences

All rights reserved.